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(cm), LV end-systolic volume (mL), posterior wall thickness
(cm), intraventricular septal thickness (cm), LV relative wall
thickness, LV dysfunction grade (0 5 none, 1 5 mild, 2 5
moderate, 3 5 severe), previous myocardial infarction, LV
ejection fraction (%)
Other Cardiac Comorbidity
Atrial fibrillation, coronary artery stenosis ($50%, any) (left
main trunk, left anterior descending coronary artery, circum-
flex coronary artery, right coronary artery), number of coro-
nary systems with . 50% stenosis, family history of
coronary artery disease, ventricular arrhythmia, complete
heart block, history of endocarditis, history of heart failure
Noncardiac Comorbidity
History of hypertension, treated diabetes (insulin treated/not
insulin treated), stroke, smoking; peripheral arterial disease,
chronic obstructive pulmonary disease, renal failure, blood
urea nitrogen (mg/dL21), creatinine (mg/dL21), bilirubin
(mg/dL21), cholesterol (mg/dL21) (total, high-density lipo-
protein, low-density lipoprotein), triglycerides (mg/dL21),
hematocrit (%)
Details of Procedure
Surgical approach (minimally invasive), mitral valve repair
details (posterior/anterior/bileaflet repair, leaflet resection,
sliding leaflet repair, chordal resection, cleft repair, leaflet su-
ture, leaflet debridement, type of anuloplasty ring), mitral
valve replacement details (mechanical or bioprosthetic, pro-
pensity for replacement), tricuspid valve repair
Experience
Date of operation, surgeon
LV, Left ventricular.
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Dr T. David (Toronto, Canada). This is another thought-provoking
study from the Cleveland Clinic surgeons. I have to confess that
when I first read the abstract last January, I questioned the validity
of the conclusion and immediately asked our statistician to analyze
our data on mitral valve surgery for MR due to degenerative disease.
I had always believed that mitral valve repair was better than mitral
valve replacement because of the importance of the mitral valve ap-
paratus in left ventricular function. Moreover, prosthetic valves are
far from perfect, and conventional wisdom is that they are associated
with a higher risk of valve-related mortality and morbidity than
valve repair.
Much to my disappointment, our statistician gave me some bad
news: Our clinical outcomes as far as survival was concerned were
identical to yours. Overall, patients who had mitral valve repair had
better long-term survival than patients who had mitral valve replace-
ment, but the 2 groups of patients were different, and when matched
by propensity score analysis, the difference in survival disappeared.
In other words, mitral valve repair did not enhance lifespan when
compared with mitral valve replacement in matched patients. How-892 The Journal of Thoracic and Cardiovascular Surgery c Apever, as in your study, the matched patients were older, had more
advanced functional classes, and had more comorbid conditions.
I remain puzzled with these results, but that is what your and our
data showed.
I had hoped to challenge your results, but I can’t. All I can ask
you is to speculate on what would the results be if we compared
the outcomes of valve repair with replacement in younger, mini-
mally symptomatic, low-risk patients, such as most that we now op-
erate on? Also, did you determine the predictors of survival in all
patients by multivariable analysis? If so, was mitral valve repair
an independent predictor of survival?
Dr Gillinov. As to the first question, this relates to our precon-
ceived notions and to beliefs about mitral valve repair that we
hold dear. We still believe that mitral valve repair is the procedure
of choice for degenerative disease. We do not have enough younger
patients with posterior prolapse who received replacement to com-
pare repair and replacement in that group. However, the mean age
of those patients is 57 years, and I have to think that if we put a me-
chanical valve or a bioprosthesis in a 57-year-old, that person will be
facing a quarter century of risk for prosthesis-related morbidity;
I believe that repair reduces these risks. Our hope and speculation
are that to have a valve repair for 25 years is superior to having
a prosthesis for 25 years.
As far as survival in all patients, mitral valve repair does not
emerge as a factor that increases overall survival. Rather, survival is
influenced more by traditional factors, including left ventricular dys-
function, advanced age, and other comorbidities. I amnot sure thatwe
will ever be able to do a prospective study that directly addresses the
survival impact of mitral valve repair when compared with replace-
ment. It is currently not feasible to take 57-year-old people with pos-
terior leaflet prolapse and randomize them to our best prosthesis or our
best repair. So we are just going to have to come at that question from
as many directions as possible using existing data.
Dr Irving Kron (Charlottesville, Va). I am fearful that the mes-
sage will be misinterpreted, and I am sure you have thought about
this. Certainly at the Cleveland Clinic you are going to do everything
you can to repair a valve. Literally less than 10% of your valves were
replaced. So the typical patient who undergoes replacement in the
United States probably has bileaflet prolapse and is younger. You
didn’t show us that group, but my suspicion would be, and certainly
our bias is, that they should be repaired. What are your thoughts
about this?
Dr Gillinov.We agree. The first thing Dr Lytle said to me about
this topic was to be careful in framing the message of this article be-
cause a reader may look at the title, draw a conclusion about mitral
valve repair, and stop there. We have carefully tried to craft the mes-
sage and point out that in the patient you have described, who is
younger with bileaflet prolapse, we would strive to repair that valve.
In addition, we repair most degenerative valves in elderly patients.
This article focuses primarily on the elderly patients with complex
pathology, the group who did have enough replacements to enable
comparison between repair and replacement.
Dr Thierry Mesana (Ottawa, Ontario, Canada). Did you see
any difference in mortality in your 2 subsets of patients, and have
you changed your policies in your institution in relation to this
study? For example, what do you do when you have a posterior leaf-
let prolapse with a moderate level of calcification in a patient aged
80 years or more?ril 2008
Gillinov et al Surgery for Acquired Cardiovascular DiseaseDr Gillinov. Let me answer the second question first, and this
relates to the many different combinations of valvular pathology.
If the valve looks repairable, we repair it, whether there is calcium,
bileaflet prolapse, or anterior leaflet prolapse. If we can repair the
valve, we do so. As far as mortality, I think that was one of the
key messages I tried to get across. Overall, repair looks better, but
when you compare matched patients, repair and replacement are
similar; but those matched patients are older and sicker, with more
complex conditions, and this message may not be generalizable to
the typical young patients undergoing repair.
Dr David Adams (New York, NY). In your propensity-matched
repairs, did calcium and bileaflet prolapse influence the success and
durability of the repair over time? In other words, your repair group
had calcification and bileaflet prolapse. Can you give us a sense that
these repairs were durable and that you actually solved their regur-
gitation over time?
DrGillinov. I thinkwhat you are suggesting is the possibility that
the matched patients undergoing repair did not do well because the
repairs were not as good or as durable as more straightforward re-
pairs.Wedid not look closely at durability in this study except to state
that the reoperation rate, which is a crude estimate of durability, was
similar after repair and replacement. Other studies (eg, Dr David’s
own study looking at bileaflet vs anterior and posterior leaflet pro-
lapse) demonstrate good durability with the complex repairs but
not as good as the durability with a standard P2 prolapse. Therefore,
it is possible that reduced durability in complex patients may influ-
ence survival. However, statistically it is challenging to determine
the relationship between 2 different outcomes of an intervention, re-
pair durability and survival both being outcomes of the operation.
Dr Christoph Knosalla (Berlin, Germany). Because preserva-
tion of the subvalvular apparatus is also important after mitral valve
replacement, I am wondering how and to what extent this has been
achieved in the patients you operated on?
Dr Gillinov. That is a good question. In this cohort, virtually all
of the patients undergoing replacement had preservation of the pos-
terior leaflet and the subvalvular apparatus, but preservation of the
anterior leaflet was less common.
Dr John Conte (Baltimore, Md). Many of us have been willing
to accept less than perfect results for repairs in some patients because
we have truly believed that repair was better. Do you think what youThe Journal of Thmay have done, and some people may interpret the results of this ar-
ticle as such, is raised the bar for what is acceptable as a repair in
a 70-year-old patient? So we might not accept a less than perfect re-
pair in a 70-year-old patient. We might in fact use a biological valve
as replacement. Your comments on that, please.
Dr Gillinov. Well, our data do not let us answer that question,
but I will speculate. I think a good replacement is better than
a bad repair, and I would not accept a bad repair, especially in some-
body who is elderly. A good replacement is superior to a bad repair.
Dr Francis C. Wells (Cambridge, UK). As the self-help philos-
opher always says, the glass is either half full or half empty, and you
can look at your results in another way and say that you have
achieved considerably good results in a difficult group of patients.
Have you had a chance to dissect out in greater detail what you
were doing in the repair group in the older, sicker, more calcified
group? Because to actually match a valve that is designed to be com-
petent ‘‘off the blocks,’’ as it were, to have the same results in that
difficult group is quite an achievement.
Dr Gillinov. We have looked at these patients in greater detail.
Among older patients with more complex valves, the majority re-
ceived a repair. The durability of these repairs is acceptable, but
not as good as durability after a standard posterior leaflet resection.
If you are going to repair these valves, you need to have a good re-
pair at the end of the day. Therefore, we leave the operating room
with a selected group of patients; we leave with the ones who had
a good repair confirmed by intraoperative transesophageal echocar-
diography. There were some patients in this series who had an at-
tempt at repair, it failed, and they left with a replacement, and I
think that that is okay, too, as long as they leave the operating
room with a mitral valve that works.
Dr Bruce Lytle (Cleveland, Ohio). What is important to re-
member, though, is that this is a setting where surgeons believe
in mitral valve repair and repair 90% of the valves in any kind of
patient with degenerative valve disease who comes in, and within
that setting, for that 10% of patients with complications and comor-
bidities, for whatever reason the valve is not repaired, it does not
seem to compromise survival. We are talking about 10% of patients
with degenerative valve disease at that extreme end of being diffi-
cult to repair. I think it is important we not lose sight of that. So
this is a small group.oracic and Cardiovascular Surgery c Volume 135, Number 4 893
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